1. Introduction {#sec0005}
===============

Hypertrophic pachymeningitis (HP) is a rare disease that is characterized by inflammatory fibrosis and thickening of the dura mater \[[@bib0005], [@bib0010]\]. Hypertrophy of the dura mater can involve both the cranial dura and the spinal cord dura; the former is referred to as hypertrophic cranial pachymeningitis (HCP) and is the most common type, while the latter is referred to as hypertrophic spinal pachymeningitis (HSP) \[[@bib0015]\], with the majority of reported cases involving the intracranial dura \[[@bib0020]\]. Although the majority of HP cases have no identifiable cause and are referred to as idiopathic hypertrophic pachymeningitis \[[@bib0015]\], various causes of HP have been identified, including infections such as tuberculosis \[[@bib0025]\], syphilis \[[@bib0010]\], neurocysticercosis \[[@bib0030]\], human T-cell lymphotrophic virus 1 (HTLV-1) \[[@bib0035]\], metabolic disease \[[@bib0040]\], intrathecal injections \[[@bib0045]\], autoimmune diseases \[[@bib0020], [@bib0050], [@bib0055], [@bib0060]\], vasculitis \[[@bib0020]\], and malignancy. Rarely has HSP been reported in association with both HTLV-1 infection and Sjogren's syndrome (SS). There have only been a few cases reported in the English literature of HP associated with HTLV-1 infection \[[@bib0035]\] and SS \[[@bib0050], [@bib0055]\] and all of which involved the cranial dura (HCP) \[[@bib0050], [@bib0055]\] and none of which had an association with both HTLV-1 infection and SS.

We report a case of thoracic spine HP associated with both HTLV-1 infection and SS; this caused severe spinal cord compression, which responded well to surgery and steroid therapy. The work has been reported in line with the SCARE criteria \[[@bib0065]\].

2. Presentation of case {#sec0010}
=======================

A 78-year-old Asian female sustained a back injury after a fall. She presented with muscle weakness of the lower extremities, was treated conservatively, and recovered fully to being able to walk unaided. Four years later, the weakness of the lower limbs recurred and progressed to inability to walk within a 1-year period. She attended a peripheral hospital, where MRI revealed hypertrophied dura mater at the T2--T10 vertebrae levels. The patient was then referred to our hospital for further evaluation and treatment.

On presentation at our hospital, the patient had normal vital signs and no alteration of consciousness. Neurological examination revealed deterioration during manual muscle testing of the lower limbs (iliopsoas muscle: 2/1, gluteus maximus muscle: 3/1, quadriceps muscle: 2/1, tibialis anterior muscle: 2/1, gastrocnemius: 3/3). The deep tendon reflexes of the lower limbs were increased, and the pathological plantar reflex was positive bilaterally. There was an absence of superficial and deep sensation below the level of T9. The patient also had urinary retention.

Examination for infection revealed elevation of anti-HBs antibody, HBc antibody, HCV antibody, and anti-HTLV-1 antibody, but there was no evidence of other viral, bacterial, and/or fungal infection Also there was no elevation of inflammatory markers except for an elevated erythrocyte sedimentation rate (ESR) of 50 mm/hour (normal: \<20 mm/hour). Rheumatoid factor was 36.6 IU/mL (normal: \<20 IU/mL), immunoglobulin (Ig) G was 2447 mg/dL (normal: 700--1600 mg/dL), IgA was 787 mg/dL (normal: 70--400 mg/dL), and IgM was 95 mg/dL (normal: 40--230 mg/dL). There was also elevation of anti-SS-A antibody (81.7 units) and antinuclear antibody (ANA; 640 units), but no elevation of other autoantibodies. Furthermore, PR3-ANCA, MPO-ANCA, and IgG4 were not elevated. Liver and renal function were normal.

Head MRI showed no abnormalities, but spinal MRI showed a hypointense mass-like lesion (hypertrophic dura) compressing the spinal cord and extending from T2 to T10 on both T1-weighted and T2-weighted imagery ([Fig. 1](#fig0005){ref-type="fig"}A--C). Examination of cerebrospinal fluid (CSF) revealed substantial elevation of total protein to 1882 mg/dL (normal: 15--60 mg/dL) and cell number to 95 cells/μL (normal: 0--5 cells/μL). Biopsy of the lip was performed by an otorhinologist and showed features associated with chronic sialadenitis. Based on these findings, we diagnosed the patient with HSP associated with HTLV-1 infection and SS.Fig. 1Sagittal view of spine MRI showing A) T1-weighted images, B) T2-weighted images, and C) gadolinium-enhanced images. Hypertrophied dura is seen in the anterior and posterior canal, with severe compression of the spinal cord from T2 to T10.Fig. 1

We performed laminectomy from T2 to T10. The yellowish-coloured thickened dura was resected from T2--T10. The adhesion between the dura mater and the arachnoid was slight, and the resection was relatively easy ([Fig. 2](#fig0010){ref-type="fig"}A). The resulting extensive defect in the dura mater was repaired by Gore-Tex patch ([Fig. 2](#fig0010){ref-type="fig"}B). The excised dura was thickened, measuring almost 17 cm in length and 6 mm in width at the widest point ([Fig. 2](#fig0010){ref-type="fig"}C, D). Examination of a biopsied section of the resected dura revealed fibrous tissue, lymphocytes, and plasmocytic invasion. Immunohistologic examination revealed that the invaded cells contained a large number of CD138 and IgG-positive plasma cells. Hence, our diagnosis was confirmed. The number of IgG4-positive cells was 10 cells/HPF, but the ratio was not higher than 40%.Fig. 2A) Intraoperative photograph showing the slight adhesion between the dura mater and the arachnoid. B) Intraoperative photograph showing the duraplasty conducted from T2 to T10. C, D) Photograph showing the resected sections of thickened dura.Fig. 2

In collaboration with a neurologist, the patient was treated with intravenous pulse steroid therapy at 1 g/day for 3 days, which was then tapered down to 20 mg/day; the patient is currently still on steroid therapy 2 years postoperatively. The muscle strength and sensation of the lower limbs gradually improved, and she was able to walk with a cane 12 weeks postoperatively. There have been no signs of recurrence in the 2 years following surgery ([Fig. 3](#fig0015){ref-type="fig"}A, B).Fig. 3Postoperative sagittal view of spine MRI showing A) T1-weighted image, and B) T2-weighted image. Spinal atrophy was improved.Fig. 3

3. Discussion {#sec0015}
=============

HSP is a very rare cause of spinal cord compression; it usually involves only a few levels of the spinal cord, but it can also occur throughout the entire spine \[[@bib0045]\]. HSP has been more often reported to involve the posterior canal \[[@bib0025]\] than the ventral. Most HSP cases are idiopathic, but secondary HSP can occur following trauma, articular rheumatism, or infections such as syphilis and tuberculosis \[[@bib0010], [@bib0060]\]. HSP has very rarely been reported in the English literature to be associated with HTLV-1 infection or SS; two cases reported HP associated with HTLV-1 infection \[[@bib0035]\], and two cases reported HP associated with SS \[[@bib0050], [@bib0055]\]. None of these cases of HP associated with HTLV-1 or SS involved the spine, they all involved the intracranial dura (HCP). HSP initially presents with progressive radicular symptoms, followed by muscle weakness, paraplegia, and sometimes also loss of bladder and bowel control \[[@bib0045], [@bib0060]\].

Of the two potential aetiologies identified in the present case, HTLV-1 and SS, it is very difficult to determine which one caused the HSP; however, there is an established relationship between HTLV-1 infection and primary SS which strongly suggest that HTLV-1 is involved in the pathogenesis of the disease in a subset of patients with Sjögren's syndrome in endemic areas \[[@bib0010], [@bib0070], [@bib0075], [@bib0080]\]. SS being an autoimmune disease caused by a combination of genetic and environmental factors such as viral infection \[[@bib0070]\]. A high HTLV-I viral load in situ is supposed to promote the production of cytokines, especially TGF-β, resulting in the fibrous change of LSG in ACA-seropositive SS patients \[[@bib0075]\]. Salivary IgA antibodies to HTLV-1 were common among seropositive patients with Sjögren's syndrome (5/7), which might be due to increased viral activity in the salivary glands \[[@bib0080]\]. HTLV-1 has also been associated with myelopathy HAM/TSP \[[@bib0085]\].

Similarly to the present case, the two previously reported cases of HCP associated with SS had elevated ESR, rheumatoid factor, SS-A antibodies, and ANA \[[@bib0050], [@bib0055]\]. In contrast, the two previously reported cases of HCP associated with HTLV-1 infection \[[@bib0035]\] had normal ESR, and were negative for rheumatoid factor, ANA, SS-A, and SS-B, except for the presence of HTLV-1 antibody detected in both serum and CSF ([Table 1](#tbl0005){ref-type="table"}).Table 1Characteristics of hypertrophic pachymeningitis associated with human T-cell lymphotrophic virus-1 infection and/or Sjogren's syndromeTable 1ReferencePatient age (years)/sexClinical featuresLaboratory examinationCerebrospinal fluid examinationLocation on brain MRIBiopsyTreatmentOutcomeFollow-upKawano et al. \[[@bib0035]\]36/MFascial weakness, double vision, headache+ anti-HTLV1 antibody+ anti-HTLV-1 antibodyDura thickening in the falx, cranial convexity of the skull base, and cerebellar tentorium--Steroid therapyImproved--Kawano et al. \[[@bib0035]\]63/MBlurry vision and a decrease in visual acuity+ anti-HTLV-1 antibody+ anti-HTLV-1 antibodyDura thickening in the falx and cerebellar tentorium--------Ashraf et al. \[[@bib0050]\]47/FDry eyes and mouth, polyarthralgia, hearing loss, and later fascial palsy+ SS-A, + SS-B, elevated rheumatoid factor--Dura mater thickening on falx and cerebellar tentorium--Steroid therapyMultiple recurrences, all treated with steroid therapy3 yearsLi et al. \[[@bib0055]\]72/MPreviously diagnosed with primary Sjogren's syndrome, headache, dizziness, general malaise, polydypsia and polyuriaElevated erythrocyte sedimentation rate, rheumatoid factor, and IgG levels.Negative findingsDura thickening on the falx and cerebral tentoriumDense, hyalinised collagen tissues, and patchy infiltrationsSteroid therapyImproved, although pituitary functions did not recover.Not well documented+ antinuclear antibody, + APCA, + AMA, + ASMAPresent study78/FLower limb paresisElevated erythrocyte sedimentation rate, rheumatoid factor, IgG, and IgAElevated protein levelsT2 to T10Lip biopsy indicated chronic sialadenitis.Laminectomy and resection of the thickened dura, steroid therapyImproved2 years postoperatively+ SS-A, + antinuclear antibody, + anti-HTLV-1 antibodyDura mater biopsy showed chronic inflammation and fibrosis[^1]

In the present case, elevation of anti-SS-A antibody, ANA, and anti-HTLV-1 antibody in serum, led us to the diagnosis of HSP; furthermore, a lip biopsy showed features associated with chronic sialadenitis, and dural biopsy showed chronic inflammation and fibrosis. Hence, the diagnosis of HSP was confirmed, and other differential diagnoses such as tuberculosis, syphilis, granulomatous lesions, and malignancies were excluded. Recently HP has been considered as an IgG4-associated disease \[[@bib0090]\], but in the present case the proportion of IgG4-positive plasma cells in the dura was less than 40%.

Plain radiographs are usually less helpful in diagnosing HP \[[@bib0025]\], while MRI is considered the best radiological diagnostic tool \[[@bib0005]\]. Hence, MRI was used in the present case to identify thoracic HP. The extensive meningeal thickening resulting in severe spinal cord compression from T2 to T10 was hypointense on both T1- and T2-weighted images.

Although it is recommended that whenever there is an identifiable disease it should be treated medically \[[@bib0020]\], because of the presence of paresis and urinary retention, we performed a T2--T10 surgical decompression by laminectomy and resected the thickened dura. Surgical treatment is becoming the first choice in recent reports of HSP \[[@bib0050]\]. Laminectomy and excision of the thickened dura has shown to be the best mode of treatment \[[@bib0025], [@bib0040]\]. Guidetti et al. also suggested removing the entire posterior surface of the hypertrophied dura beyond the apparent limit of the lesion, as this might aid in preventing recurrence of the disease \[[@bib0025]\]. The patient in the present case is still currently on steroid therapy, although the role of steroid therapy in HSP has been criticized by others \[[@bib0095]\].

Due to the risk of recurrence, long-term follow-up is very important for correct evaluation of surgical treatment of HSP \[[@bib0025]\]. In the present case, this is currently the patient's 2 years after surgery, and we have not found any manifestations of recurrence. The patient has recovered from the sensory impairment, and can walk with a cane.

4. Conclusion {#sec0020}
=============

Although HSP associated with HTLV-1 infection and SS is a very rare clinical entity, this condition can be diagnosed by the presence of motor weakness, inability to walk, thickened dura on spinal MRI, and thorough laboratory testing. For the management of HSP associated with SS and HTLV-1, we recommend surgical decompression with subsequent prolonged steroid therapy and prolonged close monitoring to achieve a good long-term outcome.
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